Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer-Reference-Cited by-同舟云学术

Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer

Published:2019-10 Issue:2 Volume:105 Page:367-375
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zhang Yuanyuan,Schoenhals Jonathan,Christie Alana,Mohamad Osama,Wang Chiachien,Bowman Isaac,Singla Nirmish,Hammers Hans,Courtney Kevin,Bagrodia Aditya,Margulis Vitaly,Desai Neil,Garant Aurelie,Choy Hak,Timmerman Robert,Brugarolas James,Hannan Raquibul

Funder

American Cancer Society

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference30 articles.

1. International variations and trends in renal cell carcinoma incidence and mortality;Znaor;Eur Urol,2015

2. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

3. Patterns of failure following surgical resection of renal cell carcinoma: Implications for adjuvant local and systemic therapy;Rabinovitch;J Clin Oncol,1994

4. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma;Kim;Urology,2011

5. Oligometastases;Hellman;J Clin Oncol,1995

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adrenal Insufficiency following Stereotactic Ablative Radiotherapy (SAbR) of Adrenal Gland Metastases;Cancers;2024-09-12

2. Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR);Cancers;2024-08-25

3. Active Surveillance in Metastatic Renal Cell Carcinoma;Journal of Kidney Cancer and VHL;2024-06-04

4. Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review;Expert Review of Anticancer Therapy;2024-06-03

5. Prognostic Factors of Oligometastasis After Stereotactic Body Radiotherapy: The Real-World Utility of the European Society for Radiotherapy and Oncology/European Organisation for Research and Treatment of Cancer Classification;Cureus;2024-05-19